Skip to main
SNX

SYNNEX (SNX) Stock Forecast & Price Target

SYNNEX (SNX) Analyst Ratings

Based on 10 analyst ratings
Buy
Strong Buy 50%
Buy 30%
Hold 20%
Sell 0%
Strong Sell 0%

Bulls say

TD Synnex Corp has demonstrated strong financial performance, with non-GAAP gross billings increasing by 12% year-over-year in fiscal Q3/25, indicating solid demand across its product offerings. In addition, the company's fiscal Q4/25 guidance projects non-GAAP gross billings to be between $23.0 billion and $24.0 billion, reflecting an 11% year-over-year growth at the midpoint, alongside a healthy estimated increase in non-GAAP EPS of 20% year-over-year. Furthermore, fiscal Q4/25 gross billings are expected to continue their upward trajectory, growing 15% year-over-year on a reported basis, signaling robust market positioning and operational strength.

Bears say

TD Synnex has reduced its fiscal 2026 non-GAAP EPS forecast, indicating potential challenges in earnings growth. The projected free cash flow for fiscal 2025 has been lowered significantly from $1.1 billion to $800 million, reflecting a deterioration in cash generation capacity. Additionally, revenue declines across geographical segments, with sales down approximately 6% in the Americas, 3% in Europe, and 10% in Asia-Pacific and Japan, further underline the company's weakening financial performance.

SYNNEX (SNX) has been analyzed by 10 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 30% recommend Buy, 20% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of SYNNEX and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About SYNNEX (SNX) Forecast

Analysts have given SYNNEX (SNX) a Buy based on their latest research and market trends.

According to 10 analysts, SYNNEX (SNX) has a Buy consensus rating as of Mar 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $168.60, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $168.60, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

SYNNEX (SNX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.